全文获取类型
收费全文 | 1514685篇 |
免费 | 125236篇 |
国内免费 | 10469篇 |
专业分类
耳鼻咽喉 | 19272篇 |
儿科学 | 47858篇 |
妇产科学 | 42434篇 |
基础医学 | 214168篇 |
口腔科学 | 39961篇 |
临床医学 | 139631篇 |
内科学 | 300760篇 |
皮肤病学 | 34535篇 |
神经病学 | 123311篇 |
特种医学 | 57773篇 |
外国民族医学 | 526篇 |
外科学 | 221577篇 |
综合类 | 49258篇 |
现状与发展 | 33篇 |
一般理论 | 495篇 |
预防医学 | 116430篇 |
眼科学 | 34486篇 |
药学 | 109253篇 |
69篇 | |
中国医学 | 8362篇 |
肿瘤学 | 90198篇 |
出版年
2021年 | 15684篇 |
2019年 | 14884篇 |
2018年 | 20011篇 |
2017年 | 15799篇 |
2016年 | 17104篇 |
2015年 | 20391篇 |
2014年 | 27839篇 |
2013年 | 38165篇 |
2012年 | 52409篇 |
2011年 | 55786篇 |
2010年 | 32920篇 |
2009年 | 30733篇 |
2008年 | 49144篇 |
2007年 | 52074篇 |
2006年 | 52461篇 |
2005年 | 50962篇 |
2004年 | 47057篇 |
2003年 | 44729篇 |
2002年 | 42818篇 |
2001年 | 76205篇 |
2000年 | 77964篇 |
1999年 | 65155篇 |
1998年 | 19098篇 |
1997年 | 17302篇 |
1996年 | 16978篇 |
1995年 | 16020篇 |
1994年 | 14438篇 |
1993年 | 13321篇 |
1992年 | 47185篇 |
1991年 | 44641篇 |
1990年 | 42611篇 |
1989年 | 40612篇 |
1988年 | 37098篇 |
1987年 | 36152篇 |
1986年 | 33575篇 |
1985年 | 31912篇 |
1984年 | 24197篇 |
1983年 | 20324篇 |
1982年 | 12358篇 |
1981年 | 10929篇 |
1979年 | 20887篇 |
1978年 | 14639篇 |
1977年 | 12152篇 |
1976年 | 11424篇 |
1975年 | 11685篇 |
1974年 | 14056篇 |
1973年 | 13599篇 |
1972年 | 12704篇 |
1971年 | 11544篇 |
1970年 | 10976篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
T. Wu L. G. Trahair M. J. Bound C. F. Deacon M. Horowitz C. K. Rayner K. L. Jones 《Diabetic medicine》2015,32(5):595-600
92.
93.
Gui-Qi Zhu Ke-Qing Shi Sha Huang Gui-Qian Huang Yi-Qian Lin Zhi-Rui Zhou Martin Braddock Yong-Ping Chen Ming-Hua Zheng 《Medicine》2015,94(11)
Major ursodeoxycholic acid (UDCA)-based therapies for primary biliary cirrhosis (PBC) include UDCA only, or combined with either methotrexate (MTX), corticosteroids (COT), colchicine (COC), or bezafibrate (BEF). As the optimum treatment regimen is unclear and warrants exploration, we aimed to compare these therapies in terms of patient mortality or liver transplantation (MOLT) and adverse events (AE).PubMed, the Cochrane Library, and Scopus were searched for randomized controlled trials up to August 31, 2014. We estimated the hazard ratios (HRs) for MOLT and odds ratios (ORs) for AE. A sensitivity analysis based on the dose of UDCA was also executed.Thirty-one eligible articles were included. Compared with COT plus UDCA, UDCA (HR 0.38, 95% confidence interval [CI] 0.09–1.39), BEF plus UDCA (HR 0.29, 95% CI 0.02–4.83), COC plus UDCA (HR 0.39, 95% CI 0.07–2.25), MTX plus UDCA (HR 0.28, 95% CI 0.05–1.63), or OBS (HR 0.49, 95% CI 0.11–2.01) all provided an increased risk of MOLT. With respect to drug AE profile, although not differing appreciably, BEF plus UDCA was associated with more AEs compared with UDCA (OR 3.16, 95% CI 0.59–20.67), COT plus UDCA (OR 2.27, 95% CI 0.15–33.36), COC plus UDCA (OR 1.00, 95% CI 0.09–12.16), MTX plus UDCA (OR 2.03, 95% CI 0.23–17.82), or OBS (OR 3.00, 95% CI 0.53–20.75). The results of sensitivity analyses were highly consistent with previous analyses.COT plus UDCA was the optimal UDCA-based regimen for both MOLT and AEs. BEF plus UDCA was most likely to cause AEs, whereas monotherapy with UDCA and coadministriation of COT plus UDCA appeared to be associated with the fewest AEs for PBC treatment. 相似文献
94.
Feasibility and Diagnostic Potential of Pulmonary Transit Time Measurement by Contrast Echocardiography: A Pilot Study
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
95.
E. M. Peterman C. Sullivan M. F. Goody I. Rodriguez-Nunez J. A. Yoder C. H. Kim 《Infection and immunity》2015,83(1):430-440
Mitochondria are known primarily as the location of the electron transport chain and energy production in cells. More recently, mitochondria have been shown to be signaling centers for apoptosis and inflammation. Reactive oxygen species (ROS) generated as by-products of the electron transport chain within mitochondria significantly impact cellular signaling pathways. Because of the toxic nature of ROS, mitochondria possess an antioxidant enzyme, superoxide dismutase 2 (SOD2), to neutralize ROS. If mitochondrial antioxidant enzymes are overwhelmed during severe infections, mitochondrial dysfunction can occur and lead to multiorgan failure or death. Pseudomonas aeruginosa is an opportunistic pathogen that can infect immunocompromised patients. Infochemicals and exotoxins associated with P. aeruginosa are capable of causing mitochondrial dysfunction. In this work, we describe the roles of SOD2 and mitochondrial ROS regulation in the zebrafish innate immune response to P. aeruginosa infection. sod2 is upregulated in mammalian macrophages and neutrophils in response to lipopolysaccharide in vitro, and sod2 knockdown in zebrafish results in an increased bacterial burden. Further investigation revealed that phagocyte numbers are compromised in Sod2-deficient zebrafish. Addition of the mitochondrion-targeted ROS-scavenging chemical MitoTEMPO rescues neutrophil numbers and reduces the bacterial burden in Sod2-deficient zebrafish. Our work highlights the importance of mitochondrial ROS regulation by SOD2 in the context of innate immunity and supports the use of mitochondrion-targeted ROS scavengers as potential adjuvant therapies during severe infections. 相似文献
96.
97.
98.
99.
100.